Glenn Coleman, EVP & Chief Financial Officer at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL), bought 10 shares at $297.43 ($3K) on 2026-09-30, disclosed to the SEC on 2026-10-02.
Open-market purchase of $3k CRL by EVP & Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| IART | SELL | 2021-11-03 | $316K | — | Filing → |
| IART | SELL | 2021-04-19 | $1.8M | — | Filing → |
| IART | SELL | 2021-04-15 | $282K | — | Filing → |